Source:http://linkedlifedata.com/resource/pubmed/id/15953502
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2005-6-14
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0168-8227
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
68 Suppl 2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
S1-2
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading | |
pubmed:year |
2005
|
pubmed:articleTitle |
Targeting dyslipidemia--the key to CHD risk reduction in the diabetic population?
|
pubmed:affiliation |
Endocrinology and Metabolism, Department of Medicine, University College London Medical School, London, UK. j.betteridge@ucl.ac.uk
|
pubmed:publicationType |
Journal Article
|